Last updated on February 2018

ALDH2 Mutation in Taiwanese Head and Neck Cancer

Brief description of study

The purpose of this study is to evaluate the effect of ALDH2 mutation in radiation associating dermatitis or mucositis in head and neck cancer patients who accept chemoradiation therapy

Detailed Study Description

  • One-site audit. The enrolled subject is confirmed by PIs
     Source data is compared to external data sources medical records, either paper or
     electronic case report forms.
  • NCI CTCAE v5.0 for AE records
  • Patient recruitment according to inclusion criteria: 1. Newly diagnosed locally head and neck squamous cell carcinoma; 2. Apply for primary chemoradiation or adjuvant chemoradiation; 3. Signed informed consent
  • Sample size assessment: 60 subjects will be included in one year for total 120 subjects
  • Missing data to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results
  • Fisher's exact test is for category comparison. Kaplan-Meier analysis is for survival analysis. AE grades will be analyzed according to NCI guideline. Two-side p < 0.05 is suggested significant.

Clinical Study Identifier: NCT02761408

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.